Annexin Pharmaceuticals AB (publ) (STO:ANNX)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.2880
+0.0080 (2.86%)
Apr 30, 2025, 12:59 PM CET
Market Cap 197.55M
Revenue (ttm) n/a
Net Income (ttm) -50.25M
Shares Out 705.53M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 980,202
Average Volume 406,290
Open 0.2800
Previous Close 0.2800
Day's Range 0.2510 - 0.2880
52-Week Range 0.2210 - 0.9320
Beta 0.70
RSI 45.71
Earnings Date Apr 11, 2025

About STO:ANNX

Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein. The company offers Annexin A5 to protect and repair blood vessels and counteract inflammation. Annexin Pharmaceuticals AB (publ) was founded in 2014 and is based in Stockholm, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 4
Stock Exchange Nasdaq Stockholm
Ticker Symbol ANNX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.